Gene Query: AMOT

Dataset Description Geneva Score
Efficient and quantitative high-throughput tRNA sequencing 156.1
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 133.28
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 90.73
Lineage specific differentiation is influenced by state of human pluripotency 90.73
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 88.16
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 88.16
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 82.38
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 79.94
Ectoderm specification of H1 human embryonic stem cells 78.43
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 78.05
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 77.28
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 70.78
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 67.21
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 66.73
RNA sequencing of BT142 and TS603 cell lines 64.3
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 64.3
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 63.65
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 62.02
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 60.8
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 60.33
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 57.58
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 56.85
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 56.44
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 53.02
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 50.32
BAF controls genome accessibility 49.5
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 45.66
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 45.66
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 44.85
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 43.96
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 43.96
NHLRC1 re-expression in cancer cells 43.03
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 43.01
Global expression profiles in cardiac progenitor cells generated by ISX-9 40.73
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 40.73
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 39.46
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 39.46
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 37.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 37.66
Role of XRN2 ribonucleolytic activity in RNA metabolism 36.8
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 32.74
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 32.44
Accurate annotation of human protein-coding small open reading frames 32.33
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 32.26
RNA-seq analysis of BAP1-depleted uveal melanoma cells 32.04
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 31.52
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 30.57
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 30.5
Effect of disulfiram treatment on pediatric high grade glioma 30.42
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 29.47
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 29.34
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 29.3
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 28.65
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 28.53
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 28.25
Mechanistic Model-Guided Study of Embryonic Morphogenesis 28.2
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 28.07
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 28.07
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 27.52
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 27.31
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 27.27
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 24.88
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 24.54
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 24.51
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 24.38
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 24.38
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 23.99
RNA-seq in transgenic cells 23.91
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 23.44
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 22.92
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 22.57
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 22.42
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 22.28
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 22.18
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 21.66
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 21.66
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 21.51
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 21.51
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 21.48
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 21.14
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 20.33
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 20.31
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 20.25
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 20.25
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 20.24
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 20.11
Comparing gene expression in iPSC derived RPE from control and AMD donors 20.0
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 19.89
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 19.89
RNA sequencing analysis of human embryonic stem cells and axial progenitors 19.79
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 19.76
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 19.62
Identifying the molecular mode of action of itraconazole in colorectal cancer 19.31
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 19.3
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 19.23
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 18.91
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 18.73
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 18.27
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 18.14
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 17.9
Epigenome regulation during epidermal lineage commitment [RNA-seq] 17.77
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 17.57
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 17.19
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 17.1
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 16.93
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 16.93
3’ Uridylation Expands miRNA Target Repertoire 16.87
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 16.87
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 16.85
Transcriptome analysis of virus infected tissues 16.83
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 16.66
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 16.66
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 16.44
The MEF2B Regulatory Network - RNA-seq data 16.36
The MEF2B Regulatory Network 16.36
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 16.33
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 16.14
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 16.08
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 15.95
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 15.95
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 15.92
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 15.85
DJ-1 is dispensable for human stem cell homeostasis 15.81
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 15.76
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 15.73
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 15.73
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 15.66
Real-time observation of light-controlled transcription in living cells 15.63
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 15.58
Role of FGFR1 in neuronal devlopment 15.57
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 15.55
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 15.39
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 15.38
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 15.29
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 15.23
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 15.15
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 15.13
Dynamic reorganization of nuclear architecture during human cardiogenesis 14.93
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 14.93
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 14.6
RNA transcriptome analysis during HSV-1 infection 14.56
Determination of tRNA aminoacylation levels by high throughput sequencing 14.53
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 14.49
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 14.31
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 14.29
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 14.16
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 14.13
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 14.08
Transcriptional responses of melanoma cells to BRAF inhibition 14.0
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 13.96
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 13.89
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 13.84
Energy Metabolism during Anchorage-Independence 13.81
Disruption of GRIN2B impairs differentiation in human neurons 13.8
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 13.74
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 13.68
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 13.64
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 13.63
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 13.63
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 13.58
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 13.58
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 13.57
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 13.56
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 13.45
RNA sequencing analysis of selumetinib-resistant CRC cells lines 13.34
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 13.16
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 13.13
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 13.13
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 12.95
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 12.93
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 12.84
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 12.8
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 12.74
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 12.67
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 12.45
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 12.45
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 12.39
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 12.32
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 12.29
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 12.11
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 12.11
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 12.1
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 12.08
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 12.08
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 12.01
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 12.01
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 11.98
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 11.95
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 11.94
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 11.87
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 11.83
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 11.67
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 11.66
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 11.59
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 11.55
Profiling of escape kinetics of viruses subjected to RNAi 11.54
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 11.52
RNA-seq analysis and shRNA screen of breast cancer 11.32
RNA-seq analysis of breast cancer 11.32
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 11.31
Genome-wide chromatin analysis of Ewing sarcoma 11.31
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 11.25
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 11.21
Identification of a LIF-responsive replication-competent human β cell 11.19
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 11.12
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 11.07
Ribosomal protein RPL26 is the principal target of UFMylation 11.05
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 11.01
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 10.96
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 10.74
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 10.68
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 10.68
Splicing and epigenetic factors jointly regulate epidermal differentiation 10.59
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 10.57
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 10.53
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 10.51
Systematic discovery of endogenous human ribonucleoprotein complexes 10.47
A role for ZNF598 in post-transcriptional gene regulation 10.44
Transcriptome of human white and brown adipose tissue biopsies 10.43
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 10.42
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 10.39
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 10.27
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 10.27
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 10.23
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 10.19
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 10.11
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 10.08
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 10.08
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 10.08
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.06
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 10.01
Transcriptional profiling of LS1034 cells treated with tepoxalin 9.98
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 9.97
Maturation of human iNSCs 9.94
Transcriptome analysis of H9 hESC derived cerebral organoids 9.93
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 9.91
Engineering Patient-Specific Tissue Implants 9.91
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 9.82
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 9.76
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 9.75
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 9.74
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 9.67
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 9.65
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 9.62
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 9.62
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 9.6
SF3B1 Degron knockdown RNA-seq 9.51
High level DNA repair gene expression in human ES cells 9.5
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.44
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 9.4
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 9.36
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 9.34
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 9.22
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 9.19
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 9.19
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 9.14
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.14
Gene expression analysis upon mtDNA depletion 9.11
Gene expression analysis upon mtDNA depletion [RNA-seq] 9.11
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 9.08
FOXP2's impact on the primate transcriptome 9.07
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 9.05
hESC neural differentiation 9.0
RNA-seq analysis of gene expression patterns during hESC neural differentiation 9.0
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 8.93
Derivation and differentiation of haploid human embryonic stem cells 8.86
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 8.82
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.75
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 8.7
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 8.69
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 8.69
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 8.68
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 8.62
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 8.57
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 8.56
Functional astrocytes differentiated from hiPSCs 8.5
RNA-seq analysis of RALD iPSCs after in vitro differentiation 8.41
METTL3 and WTAP 8.39
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 8.28
Transcriptome analysis of Zika infected neural stem cells 8.1
Zika infected neural stem cells 8.1
Human cell line and subcutaneous tumor 8.09
Examining serotonergic neuron differentiation from human iPSCs 8.06
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 8.06
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 8.04
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 7.93
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 7.83
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 7.83
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 7.79
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 7.78
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 7.73
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 7.69
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 7.66
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 7.63
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 7.62
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 7.49
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 7.43
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 7.41
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 7.41
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.39
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 7.36
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.35
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.35
Zika virus directly infects human peripheral neurons and induces cell death 7.33
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 7.33
7.32
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 7.29
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 7.25
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 7.18
Novel Targeting of Transcription and Metabolism in Glioblastoma 7.17
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 7.17
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 7.11
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 7.11
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 7.0
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 7.0
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 6.99
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 6.99
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 6.99
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 6.91
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 6.88
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 6.85
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 6.79
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.76
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 6.74
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.64
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 6.64
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 6.57
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.56
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 6.56
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.49
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 6.47
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 6.42
Gene expression patterns define the hepatocyte-like cells derived by different strategies 6.42
Genome-wide identification of cancer-specific alternative splicing in circRNA 6.29
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 6.2
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 6.17
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.17
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 6.17
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 6.09
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 6.08
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 6.02
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.99
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.98
iPSC derived motor neuron cultures from C9ORF72 carriers 5.96
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 5.91
Global epigenomic reconfiguration during mammalian brain development 5.72
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.69
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 5.68
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 5.66
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 5.61
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.61
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 5.51
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 5.49
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 5.43
Transcriptomic profile of human embryonic renal corpuscles 5.41
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 5.38
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 5.35
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.29
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 5.0
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 4.99
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 4.99
iPSC-Derived Cholangiocytes 4.97
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.93
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.93
MRTF activates TEAD-YAP target gene expression 4.92
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 4.78
RNA-seq melanoma 4.75
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 4.68
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 4.64
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.63
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 4.63
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.56
RNA-seq of cancer cell lines treated with T-025 4.53
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 4.47
Changes in human endometrial gland transcriptome over the window of implantation 4.33
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 4.23
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.22
Epigenome regulation during epidermal lineage commitment 4.22
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 4.21
RNA-sequencing 4.11
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 4.04
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 4.04
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 3.97
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 3.97
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.86
Regionally specified human pluripotent stem cell-derived astrocytes 3.8
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.79
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.74
Gene expression profile of human placenta from T. Cruzi infected mothers 3.67
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 3.66
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 3.6
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 3.47
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.4
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 3.4
Dissecting neural differentiation regulatory networks through epigenetic footprinting 3.38
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.3
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.2
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.18
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.18
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 3.15
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 3.1
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 3.1
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 2.92
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.91
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.91
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.9
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.82
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.75
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.75
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 2.74
Fusion discovery in breast cancer cell line 2.65
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 2.55
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.55
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.55
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 2.54
JAK dependent survival of ALK- ALCL 2.54
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.48
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.45
Loss of endometrial plasticity in recurrent pregnancy loss 2.41
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.41
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 2.39
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 2.39
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 2.39
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 2.33
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.33
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.26
RNAseq analysis of ruxolitinib treated breast cancers 2.25
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 2.15
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.15
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 2.11
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.94
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.94
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.78
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 1.76
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 1.69
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.67
Differential gene expression of human melanoma cells [RNA-seq] 1.67
BI Human Reference Epigenome Mapping Project 1.62
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.62
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.59
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.5
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.49
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.45
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 1.43
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.42
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.41
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.4
The cohesin release factor WAPL restricts chromatin loop extension. 1.4
Transcriptomic analysis of frontal fibrosing alopecia 1.34
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.34
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.31
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.3
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.27
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.27
Global gene expression profile of dasatinib-resistant RCH-ACV cells 1.15
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 1.12
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.07
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.04
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.04
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.03
RNA-seq of SCLC PDX models treated with EP 0.89
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.87
SOX11 knockdown in B-ALL cell lines 0.85
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.82
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.81
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.78
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.77
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.7
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.68
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.67
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.65
Deep RNA sequencing of the human placental transcriptome 0.61
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.61
Expression profiles of the four human major ectodermal lineages 0.6
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.56
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.53
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.52
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.48
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.44
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.38
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 0.38
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.37
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.37
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.37
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.35
Epigenomic conservation of transposable element silencing [RNA-seq] 0.35
Epigenomic conservation of transposable element silencing 0.35
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.31
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 0.31
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.29
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.27
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.25
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.23
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.19
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.16
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.14
Transcriptome of EBV-infected gastric cancer cell lines 0.07
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.03
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.0
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation